(Recall story updated with more analyst commentary and stock price) NEW YORK ( TheStreet ) -- What will be the financial impact of recalls by Johnson & Johnson's ( JNJ ) DePuy Orthopaedics unit of two hip replacement devices and the company's recent contact lens recalls -- only days after receiving a warning letter from the U.S. Food and Drug Administration for violating FDA rules by marketing two orthopedic products without proper approval or clearance?